Rezolute (RZLT) Enterprise Value (2010 - 2026)
Rezolute (RZLT) posted Enterprise Value of -$120.2 million for Q1 2026, up 9.56% sequentially from -$132.9 million in Q4 2025, and down 38.36% YoY from -$195.0 million in Q1 2025.
Rezolute (RZLT) Enterprise Value (2010 - 2026) Analysis & Trends
Rezolute has reported Enterprise Value for 13 years, with the latest figure at -$120.2 million in Q1 2026.
- Quarterly Enterprise Value fell 38.36% year-over-year to -$120.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$120.2 million (down 38.36% YoY) and the FY2025 annual result came in at -$167.9 million, down 32.3% from the prior year.
- Enterprise Value rose to -$120.2 million in Q1 2026 per RZLT's latest filing, from -$132.9 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$63.4 million in Q1 2022 and troughed at -$167.9 million in Q2 2025.
- A 5-year average of -$116.7 million and a median of -$108.3 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value sank 313.82% in 2022, then soared 36.9% in 2023.
- Over 5 years, Enterprise Value stood at -$146.7 million in 2022, then jumped by 36.9% to -$92.6 million in 2023, then declined by 4.25% to -$96.5 million in 2024, then plunged by 37.71% to -$132.9 million in 2025, then advanced by 9.56% to -$120.2 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$120.2 million, -$132.9 million, and -$152.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - | -120.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -120.23 Mn |
| Dec 31, 2025 | -132.94 Mn |
| Sep 30, 2025 | -152.20 Mn |
| Jun 30, 2025 | -167.86 Mn |
| Mar 31, 2025 | -86.90 Mn |
| Dec 31, 2024 | -96.54 Mn |
| Sep 30, 2024 | -108.27 Mn |
| Jun 30, 2024 | -126.87 Mn |
| Mar 31, 2024 | -80.02 Mn |
| Dec 31, 2023 | -92.60 Mn |
| Sep 30, 2023 | -98.80 Mn |
| Jun 30, 2023 | -101.90 Mn |
| Mar 31, 2023 | -103.02 Mn |
| Dec 31, 2022 | -146.75 Mn |
| Sep 30, 2022 | -154.32 Mn |
| Jun 30, 2022 | -150.41 Mn |
| Mar 31, 2022 | -63.42 Mn |
| Dec 31, 2021 | -77.40 Mn |
| Sep 30, 2021 | -37.29 Mn |
| Jun 30, 2021 | -41.05 Mn |